{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T05:22:05Z","timestamp":1698643325741},"reference-count":47,"publisher":"Elsevier BV","issue":"2","content-domain":{"domain":["rbmojournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive BioMedicine Online"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.rbmo.2013.10.012","type":"journal-article","created":{"date-parts":[[2013,10,25]],"date-time":"2013-10-25T06:34:32Z","timestamp":1382682872000},"page":"183-190","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Ovarian response markers lead to appropriate and effective use of corifollitropin alpha in assisted reproduction"],"prefix":"10.1016","volume":"28","author":[{"given":"Antonio","family":"La Marca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"D\u2019Ippolito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rbmo.2013.10.012_b0005","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10815-009-9319-5","article-title":"Prediction of high ovarian response to controlled ovarian hyperstimulation: anti-M\u00fcllerian hormone versus small antral follicle count (2\u20136 mm)","volume":"26","author":"Aflatoonian","year":"2009","journal-title":"J. Assist. Reprod. Genet."},{"key":"10.1016\/j.rbmo.2013.10.012_b0010","doi-asserted-by":"crossref","first-page":"6297","DOI":"10.1210\/jc.2004-0668","article-title":"Pharmacodynamics of a single low dose of long-acting recombinant follicle-stimulating hormone (FSH-carboxy terminal peptide, corifollitropin alfa) in women with World Health Organization group II anovulatory infertility","volume":"89","author":"Balen","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.rbmo.2013.10.012_b0015","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.fertnstert.2012.02.038","article-title":"Engage investigators. A comparison of live birth rates and cumulative ongoing pregnancy rates between Europe and North America after ovarian stimulation with corifollitropin alfa or recombinant follicle-stimulating hormone","volume":"97","author":"Boostanfar","year":"2012","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2013.10.012_b0020","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/j.fertnstert.2012.07.125","article-title":"A large double blind efficacy and safety trial of corifollitropin alfa versus daily recombinant FSH in women 35 to n42 years of age undergoing ovarian stimulation prior to IVF or ICSI (Pursue trial)","volume":"98","author":"Boostanfar","year":"2012","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2013.10.012_b0025","first-page":"1490","volume":"15","author":"Borm","year":"2001","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2013.10.012_b0030","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1093\/humrep\/16.8.1592","article-title":"FSH-CTP study group. First human exposure to FSH-CTP in hypogonadotrophic hypogonadal males","volume":"16","author":"Bouloux","year":"2001","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2013.10.012_b0035","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/humupd\/dmq034","article-title":"AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis","volume":"17","author":"Broer","year":"2011","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.rbmo.2013.10.012_b0040","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1093\/humrep\/den288","article-title":"A randomized dose-response trial of a single injection of corifollitropin alfa to sustain multifollicular growth during controlled ovarian stimulation","volume":"23","author":"Corifollitropin Alfa Dose-finding Study Group","year":"2008","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2013.10.012_b0045","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.rbmo.2010.03.019","article-title":"Corifollitropin alfa for ovarian stimulation in IVF: a randomized trial in lower-body-weight women","volume":"21","author":"Corifollitropin alfa Ensure Study Group","year":"2010","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.rbmo.2013.10.012_b0050","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/clpt.2010.54","article-title":"Dose selection of corifollitropin alfa by modeling and simulation in controlled ovarian stimulation","volume":"88","author":"de Greef","year":"2010","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.rbmo.2013.10.012_b0055","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/molehr\/2.5.361","article-title":"Structure-function relationship of recombinant follicle stimulating hormone (Puregon)","volume":"2","author":"de Leeuw","year":"1996","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.rbmo.2013.10.012_b0065","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1210\/jc.2003-031766","article-title":"Induction of multiple follicular development by a single dose of long-acting recombinant follicle-Stimulating hormone (FSH-CTP, corifollitropin alfa) for controlled ovarian stimulation before in vitro fertilization","volume":"89","author":"Devroey","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.rbmo.2013.10.012_b0060","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1093\/humrep\/dep291","article-title":"ENGAGE Investigators. A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol","volume":"24","author":"Devroey","year":"2009","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2013.10.012_b0070","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1093\/humrep\/17.8.1987","article-title":"Single dose pharmacokinetics and effects on follicular growth and serum hormones of a long-acting recombinant FSH preparation (FSH-CTP) in healthy pituitary-suppressed females","volume":"17","author":"Duijkers","year":"2002","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2013.10.012_b0075","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1093\/humrep\/dei203","article-title":"Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome","volume":"20","author":"Eldar-Geva","year":"2005","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2013.10.012_b0080","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/humrep\/16.4.644","article-title":"Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation","volume":"16","author":"European and Middle East Orgalutran Study Group","year":"2001","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2013.10.012_b0085","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.1073\/pnas.89.10.4304","article-title":"Design of a long-acting follitropin agonist by fusing the C-terminal sequence of the chorionic gonadotropin beta subunit to the follitropin beta subunit","volume":"89","author":"Fares","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.rbmo.2013.10.012_b0095","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/humupd\/dmn065","article-title":"Advances in recombinant DNA technology: corifollitropin alfa, a hybrid molecule with sustained follicle-stimulating activity and reduced injection frequency","volume":"15","author":"Fauser","year":"2009","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.rbmo.2013.10.012_b0090","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.rbmo.2010.06.032","article-title":"Mannaerts BM; Engage Investigators. Pharmacokinetics and follicular dynamics of corifollitropin alfa versus recombinant FSH during ovarian stimulation for IVF","volume":"21","author":"Fauser","year":"2010","journal-title":"Reprod Biomed Online."},{"key":"10.1016\/j.rbmo.2013.10.012_b0100","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/humupd\/2.2.172","article-title":"Genetic engineering of human FSH (Gonal-F)","volume":"2","author":"Howles","year":"1996","journal-title":"Hum. Reprod. Update."},{"key":"10.1016\/j.rbmo.2013.10.012_b0105","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1093\/humrep\/dep246","article-title":"GnRHa to trigger final oocyte maturation: a time to reconsider","volume":"24","author":"Humaidan","year":"2009","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2013.10.012_b0110","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.fertnstert.2007.07.1293","article-title":"Evaluation of anti-M\u00fcllerian hormone as a test for the prediction of ovarian reserve","volume":"90","author":"Kwee","year":"2008","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2013.10.012_b0115","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/humrep\/del421","article-title":"Anti-M\u00fcllerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology","volume":"22","author":"La Marca","year":"2007","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2013.10.012_b0120","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/humupd\/dmp036","article-title":"Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)","volume":"16","author":"La Marca","year":"2010","journal-title":"Hum. Reprod. Update."},{"key":"10.1016\/j.rbmo.2013.10.012_b0125","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.fertnstert.2010.07.1069","article-title":"Age-specific nomogram for the decline in antral follicle count throughout the reproductive period","volume":"95","author":"La Marca","year":"2011","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2013.10.012_b0240","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/humupd\/dmt037","article-title":"Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice","volume":"20","author":"La Marca","year":"2014","journal-title":"Hum. Reprod. Update."},{"key":"10.1016\/j.rbmo.2013.10.012_b0135","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1210\/endo.131.6.1446593","article-title":"Enhanced stimulation of follicle maturation and ovulatory potential by long acting follicle-stimulating hormone agonists with extended carboxyl-terminal peptides","volume":"131","author":"LaPolt","year":"1992","journal-title":"Endocrinology"},{"key":"10.1016\/j.rbmo.2013.10.012_b0140","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0015-0282(97)00503-7","article-title":"Pharmacokinetic and pharmacodynamic interactions between recombinant human luteinizing hormone and recombinant human follicle-stimulating hormone","volume":"69","author":"le Cotonnec","year":"1998","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2013.10.012_b0145","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.rbmo.2011.04.002","article-title":"Corifollitropin alfa doses based on body weight: clinical overview of drug exposure and ovarian response","volume":"23","author":"Ledger","year":"2010","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2013.10.012_b0150","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/humrep\/dem254","article-title":"Serum anti-M\u00fcllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles","volume":"23","author":"Lee","year":"2008","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2013.10.012_b0155","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/humrep\/11.suppl_5.95","article-title":"Clinical assessment of human gonadotrophins produced by recombinant DNA technology","volume":"11","author":"Loumaye","year":"1996","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2013.10.012_b0160","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2217\/whe.10.56","article-title":"Corifollitropin alfa: a novel long-acting recombinant follicle-stimulating hormone agonist for controlled ovarian stimulation","volume":"6","author":"Loutradis","year":"2010","journal-title":"Womens Health (Lond. Engl.)"},{"key":"10.1016\/j.rbmo.2013.10.012_b0165","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.fertnstert.2008.08.127","article-title":"Circulating basal anti-M\u00fcllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization","volume":"92","author":"Nardo","year":"2009","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2013.10.012_b0170","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1093\/humrep\/dem204","article-title":"Serum anti-M\u00fcllerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles\u2013implications for individualization of therapy","volume":"22","author":"Nelson","year":"2007","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2013.10.012_b0175","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s10815-005-6785-2","article-title":"The significance of antral follicle count in controlled ovarian stimulation and intrauterine insemination","volume":"22","author":"Ng","year":"2005","journal-title":"J. Assist. Reprod. Genet."},{"key":"10.1016\/j.rbmo.2013.10.012_b0180","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s10815-011-9627-4","article-title":"Serum anti-M\u00fcllerian hormone and antral follicle count as predictive markers of OHSS in ART cycles","volume":"28","author":"Ocal","year":"2011","journal-title":"J. Assist. Reprod. Genet."},{"key":"10.1016\/j.rbmo.2013.10.012_b0185","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/molehr\/2.5.371","article-title":"Molecular biology and biochemistry of human recombinant follicle stimulating hormone (Puregon)","volume":"2","author":"Olijve","year":"1996","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.rbmo.2013.10.012_b0195","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.fertnstert.2012.09.043","article-title":"Corifollitropin alfa followed by rFSH in a GnRH antagonist protocol for poor ovarian responder patients: an observational pilot study","volume":"99","author":"Polyzos","year":"2013","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2013.10.012_b0190","doi-asserted-by":"crossref","unstructured":"Polyzos NP, Tournaye H, Guzman L, Camus M, Nelson SM. Predictors of ovarian response in women treated with corifollitropin alfa for in vitro fertilization\/intracytoplasmic sperm injection. Fertil Steril. 2013b May 11 [Epub ahead of print].","DOI":"10.1016\/j.fertnstert.2013.04.029"},{"key":"10.1016\/j.rbmo.2013.10.012_b0200","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0015-0282(16)56646-1","article-title":"Clinical pharmacology of recombinant human follicle-stimulating hormone. III. Pharmacokinetic-pharmacodynamic modelling after repeated subcutaneous administration","volume":"61","author":"Porchet","year":"1994","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2013.10.012_b0205","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.rbmo.2011.09.017","article-title":"Meta-analysis of GnRH antagonist protocols: do they reduce the risk of OHSS in PCOS?","volume":"24","author":"Pundir","year":"2012","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2013.10.012_b0210","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0015-0282(16)58408-8","article-title":"Efficacy of recombinant follicle-stimulating hormone","volume":"66","author":"Quinton","year":"1996","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2013.10.012_b0215","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.rbmo.2012.11.015","article-title":"Evaluation of the degree of satisfaction in oocytes donors using sustained-release FSH corifollitropin alfa","volume":"26","author":"Requena","year":"2013","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2013.10.012_b0220","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.rbmo.2012.01.005","article-title":"Comparative incidence of ovarian hyperstimulation syndrome following ovarian stimulation with corifollitropin alfa or recombinant FSH","volume":"24","author":"Tarlatzis","year":"2012","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2013.10.012_b0225","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1093\/humrep\/17.12.3065","article-title":"Serum anti-M\u00fcllerian hormone levels: a novel measure of ovarian reserve","volume":"17","author":"van Rooij","year":"2002","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2013.10.012_b0230","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1093\/humrep\/den219","article-title":"Why do couples drop-out from IVF treatment? A prospective cohort study","volume":"23","author":"Verberg","year":"2008","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2013.10.012_b0235","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1055\/s-0030-1265669","article-title":"Ovarian hyperstimulation syndrome: definition, incidence, and classification","volume":"28","author":"Zivi","year":"2010","journal-title":"Semin. Reprod. Med."}],"container-title":["Reproductive BioMedicine Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648313005385?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648313005385?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T08:58:50Z","timestamp":1564563530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472648313005385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S1472648313005385"],"URL":"https:\/\/doi.org\/10.1016\/j.rbmo.2013.10.012","relation":{},"ISSN":["1472-6483"],"issn-type":[{"value":"1472-6483","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ovarian response markers lead to appropriate and effective use of corifollitropin alpha in assisted reproduction","name":"articletitle","label":"Article Title"},{"value":"Reproductive BioMedicine Online","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rbmo.2013.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}